Literature DB >> 26864275

CoNVaDING: Single Exon Variation Detection in Targeted NGS Data.

Lennart F Johansson1,2, Freerk van Dijk1,2, Eddy N de Boer1, Krista K van Dijk-Bos1, Jan D H Jongbloed1, Annemieke H van der Hout1, Helga Westers1, Richard J Sinke1, Morris A Swertz1,2, Rolf H Sijmons1, Birgit Sikkema-Raddatz1.   

Abstract

We have developed a tool for detecting single exon copy-number variations (CNVs) in targeted next-generation sequencing data: CoNVaDING (Copy Number Variation Detection In Next-generation sequencing Gene panels). CoNVaDING includes a stringent quality control (QC) metric, that excludes or flags low-quality exons. Since this QC shows exactly which exons can be reliably analyzed and which exons are in need of an alternative analysis method, CoNVaDING is not only useful for CNV detection in a research setting, but also in clinical diagnostics. During the validation phase, CoNVaDING detected all known CNVs in high-quality targets in 320 samples analyzed, giving 100% sensitivity and 99.998% specificity for 308,574 exons. CoNVaDING outperforms existing tools by exhibiting a higher sensitivity and specificity and by precisely identifying low-quality samples and regions.
© 2016 WILEY PERIODICALS, INC.

Entities:  

Keywords:  CNV; NGS; clinical diagnostics; exon deletion/duplication; targeted next-generation sequencing

Mesh:

Year:  2016        PMID: 26864275     DOI: 10.1002/humu.22969

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  30 in total

Review 1.  Navigating genetic diagnostics in patients with hearing loss.

Authors:  Christina M Sloan-Heggen; Richard J H Smith
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

2.  panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.

Authors:  Gundula Povysil; Antigoni Tzika; Julia Vogt; Verena Haunschmid; Ludwine Messiaen; Johannes Zschocke; Günter Klambauer; Sepp Hochreiter; Katharina Wimmer
Journal:  Hum Mutat       Date:  2017-05-16       Impact factor: 4.878

3.  A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients.

Authors:  Junxiao Zhang; Xiaoyan Wang; Richarda M de Voer; Jayne Y Hehir-Kwa; Eveline J Kamping; Robbert D A Weren; Marcel Nelen; Alexander Hoischen; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge; Xiangling Yang; Zihuan Yang; Xinjuan Fan; Lei Wang; Huanliang Liu; Jianping Wang; Roland P Kuiper; Ad Geurts van Kessel
Journal:  Oncotarget       Date:  2017-04-11

4.  Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing.

Authors:  Meng Yu; Yiming Zheng; Suqin Jin; Qiang Gang; Qingqing Wang; Peng Yu; He Lv; Wei Zhang; Yun Yuan; Zhaoxia Wang
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

5.  WISExome: a within-sample comparison approach to detect copy number variations in whole exome sequencing data.

Authors:  Roy Straver; Marjan M Weiss; Quinten Waisfisz; Erik A Sistermans; Marcel J T Reinders
Journal:  Eur J Hum Genet       Date:  2017-11-08       Impact factor: 4.246

6.  Validation of copy number variation analysis for next-generation sequencing diagnostics.

Authors:  Jamie M Ellingford; Christopher Campbell; Stephanie Barton; Sanjeev Bhaskar; Saurabh Gupta; Rachel L Taylor; Panagiotis I Sergouniotis; Bradley Horn; Janine A Lamb; Michel Michaelides; Andrew R Webster; William G Newman; Binay Panda; Simon C Ramsden; Graeme Cm Black
Journal:  Eur J Hum Genet       Date:  2017-04-05       Impact factor: 4.246

7.  arrEYE: a customized platform for high-resolution copy number analysis of coding and noncoding regions of known and candidate retinal dystrophy genes and retinal noncoding RNAs.

Authors:  Caroline Van Cauwenbergh; Kristof Van Schil; Robrecht Cannoodt; Miriam Bauwens; Thalia Van Laethem; Sarah De Jaegere; Wouter Steyaert; Tom Sante; Björn Menten; Bart P Leroy; Frauke Coppieters; Elfride De Baere
Journal:  Genet Med       Date:  2016-09-08       Impact factor: 8.822

8.  Assessment of the incorporation of CNV surveillance into gene panel next-generation sequencing testing for inherited retinal diseases.

Authors:  Jamie M Ellingford; Bradley Horn; Christopher Campbell; Gavin Arno; Stephanie Barton; Catriona Tate; Sanjeev Bhaskar; Panagiotis I Sergouniotis; Rachel L Taylor; Keren J Carss; Lucy F L Raymond; Michel Michaelides; Simon C Ramsden; Andrew R Webster; Graeme C M Black
Journal:  J Med Genet       Date:  2017-10-26       Impact factor: 6.318

9.  Combining targeted panel-based resequencing and copy-number variation analysis for the diagnosis of inherited syndromic retinopathies and associated ciliopathies.

Authors:  Iker Sanchez-Navarro; Luciana R J da Silva; Fiona Blanco-Kelly; Olga Zurita; Noelia Sanchez-Bolivar; Cristina Villaverde; Maria Isabel Lopez-Molina; Blanca Garcia-Sandoval; Saoud Tahsin-Swafiri; Pablo Minguez; Rosa Riveiro-Alvarez; Isabel Lorda; Rocío Sanchez-Alcudia; Raquel Perez-Carro; Diana Valverde; Yichuan Liu; Lifeng Tian; Hakon Hakonarson; Almudena Avila-Fernandez; Marta Corton; Carmen Ayuso
Journal:  Sci Rep       Date:  2018-03-27       Impact factor: 4.379

10.  PRDX1 gene-related epi-cblC disease is a common type of inborn error of cobalamin metabolism with mono- or bi-allelic MMACHC epimutations.

Authors:  Catia Cavicchi; Abderrahim Oussalah; Silvia Falliano; Lorenzo Ferri; Alessia Gozzini; Serena Gasperini; Serena Motta; Miriam Rigoldi; Giancarlo Parenti; Albina Tummolo; Concetta Meli; Francesca Menni; Francesca Furlan; Marta Daniotti; Sabrina Malvagia; Giancarlo la Marca; Céline Chery; Pierre-Emmanuel Morange; David Tregouet; Maria Alice Donati; Renzo Guerrini; Jean-Louis Guéant; Amelia Morrone
Journal:  Clin Epigenetics       Date:  2021-07-02       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.